Cat No : 195000. TheBinaxNOWTM COVID-19 Ag Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset.
Here we are finding distributor for corona virus Ab IgG/IgM whole blood rapid test device kit and Antigen Ag rapid test card, very high quality, CE mark is available! Covid Ab IgG/IgM Ab Whole blood test device Sensitivity: 99.6% Specificity: 99.31% Accuracy: 99.5% Covid Antigen Ag swab rapid test card Sensitivity: 96.17% Specificity: >99.9% Accuracy: 98.79% 10 miuntes to get the result. MOQ for each: 500 tests, 25 tests/box,
STANDARD M nCoV Real-Time Detection kit is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples. - One tube reaction for identification and detection of 2019-nCoV - One-step Real-Time RT-PCR - Provide all reagents required for PCR - Designed according to WHO interim guidance for laboratory testing for 2019 novel coronavirus (2019-nCoV) in humans" - nCoV primers/probes ORF1ab (RdRp) gene, E gene Provide Internal controls Kindly check ghope-ppe.com. All information is for a consumer. If you want to buy a bulk, please contact us.
COVID 19 RApid Test Kit
Information Detail Test time Within 15 mins Specimen Whole blood/Serum/plasma Storage temperature 2-30/36-86 The BIOGENIX COVID-19 Rapid Test Kit is a qualitative lateral flow immunochromatographic assay for the detection of IgM and IgG antibodies to SARS-CoVID-19 in human whole blood, serum or plasma samples. It is intended for use as a tool to assist in the diagnosis of SARS-CoVID-19 infections. It is also intended as a tool for carrying out serological epidemiological investigations.
Covid Rapid Test, CE and CFDA certified, export licenses and local Chinese authorities approval.
Covi-G (powered by Cipla) Rapid Test kit combines quality, efficacy and convenience - offering precise results in 10-15 mins Features & Benefits Covid IgM-IgG Serologic Rapid Test for COVID-19 is used to qualitatively detect IgG and IgM antibodies against SARS-CoV-2 in whole blood in vitro Precise and effective - Tests for both IgM and IgG antibodies - Sensitivity and specificity comparable to highest available offerings Sensitivity: IgG 92%, IgM 82%; Specificity IgG 97%, IgM 94% - ->92% total accuracy: IgG 96,5% - IgM: 92,8% - High reproducibility (consistent results across the same patient) - High quality, reliable & convenient - Single-prick blood test - 10-15 minutes per test - Intuitive visual interpretation - No specialized training or equipment needed - Portable hence highly scalable - Storage at room temperature (2-30 C) - Conformance to CE (Europe) and ISO manufacturing The Covi-G platform for Rapid Antibody tests has a set of unique and unparalleled offerings SUSTAINABLE QUALITY Validated Declaration of CE conformity - Launched in Feb 2020, among the earliest technologies/ kits to declare CE-compliance, and continuing strong compared to competitors - Under process for receiving USDA E authorization Among only 3 integrated vendors of Rapid tests Developed and manufactured in Europe (Belgium) - One of the very lew players manufacturing in Europe, with zero complaints also certified locations ACCEPTABILITY ACROSS MARKETS Demonstrated capabilities in local countries validation - Independent local studies conducted in Belgium and France, validating the sensitivity and specificity of the product Participated in published research - Covl-G kit compared lavorably with 7 lgFL IgM rapid antibody tests and IgG ELISA in a comparative study published by Elsevier Science Direct, verifying sensitivity of the kit PROVEN COMMERCIAL EXPERIENCE Sold in 25+ countries already - Including Europe, US, Canada, Africa and multiple developed and emerging markets - Under participation in govt tenders Robust manufacturing capability and capacity - ISO-certified manufacturing site - Ability to cater to high manufacturing volumes from Belgium, to ensure adequale QA and commercial viability AFFORDABLE AND SCALABLE Viable to scale up at Institutions and Retail level - Economical cost per-unit established over many months of process improvement and local manufacturing - Can cater to insured as well as out-of pocket populations Continuous improvement through R&D - Multiple rounds of performance testing complete, further testing in 5 reputed hospitals underway in Belgium, France, USA and Canada - Other platforms including Rapid antigen testing also being developed The price is per unit, the minimum is 25000 units
COVID 19 Rapid Test Kit - Approved already in several asian countries. Made in FDA approved facility. MOQ: 10,000
Rapid test kit made in South Korea.
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. View File Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. View File Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
1. Generic Name: Novel Coronavirus COVID-19 IgG Antigen Test Kit 2. Brand Name: NIL 3. Notified Category: Other than above substances intended for qualitative determination of COVID-19 infection 4. Class of Medical Device: Class D 5. Shelf life :15 months 6. Sterile/Non-Sterile: Non-Sterilized 7. Contains Drugs: No 8. Medical Device Grouping Category: IVD-Kit 9. Grouping Description: Intended for qualitative determination of COVID-19 infection 10. Intended Use: The Novel Coronavirus COVID-19 IgG Kit is intended for the qualitative detection of human anti-COVID- 19 IgG antibody in human serum/plasma. Any reactive specimen with the Novel Coronavirus COVID-19 IgG Kit must be confirmed with alternative testing method(s). 11. Product Description: Assay controls and 1:10 diluted human serum samples are added to the microtiter wells of a microplate that was coated with COVID-19 recombinant full length recombinant protein. After the first incubation period, the unbound protein matrix is removed with a subsequent washing step. A horseradish peroxidase (HRP) labeled polyclonal goat anti-human IgG tracer antibody is added to each well. After an incubation period, an immunocomplex of "COVID-19 recombinant antigen-human anti-COVID-19 IgG antibody - HRP labeled anti human IgG tracer antibody" is formed if there is specific Coronavirus IgG antibody present in the tested specimen. The unbound tracer antibody is removed by the subsequent washing step. HRP-Labeled tracer antibody bound to the well is then incubated with a substrate solution in a timed reaction and then measured in a spectrophotometric microplate reader. The enzymatic activity of the tracer antibody bound to the anti-COVID-19 IgG on the wall of the microtiter well is proportional to the amount of the anti-COVID-19 IgG antibody level in the tested specimen. SALIENT FEATURES: â?¢ Recombinant COVID-19 Spike subunit Protein coated on Microwell Plate â?¢ HRP Conjugated Polyvalent Anti-Human IgG â?¢ Assay Time: 80 mins (30mins+30 Mins+20mins) â?¢ Strip Format Microwell Plate â?¢ Ready to use Substrate and Controls â?¢ Only 20 pL of human serum is required for measurement in duplicate. â?¢ Works on any open ELISA system â?¢ Assay procedure is easy to automate OUR TEST: â?¢ Principle: Indirect ELISA â?¢ The normal healthy patients with samples collected prior to the COVID-19 outbreak [December 3, 2019] (n = 150) and RT-PCR confirmed positive patients in after the second week of the onset of the disease (n = 32). The Positive sample evaluation was done at external Approved Lab. The results are as follows: â?¢ Diagnostic sensitivity is 100% (>98%) â?¢ Diagnostic specificity is 98.67% (>97%) â?¢ PPV: 94.12�°/0 â?¢ NPV: 100% Please contact us for more information and product details.
Quantity: 250,000 (250K) Lyher - 1 tests per package - price ¬ 1.70 officially approved by the BfArM test suitable for lay use rapid sampling through the nose user-friendly step-by-step instructions Test result within 15 minutes LYHER Novel Coronavirus (COVID-19) Antigen Test Kit (Colloidal Gold) from the manufacturer Hangzhou Laihe Biotech Co., Ltd., China If interested, just let us know Quantity: 250.000 (250K) Lyher â?? 1 tests per package â?? Preis â?¬1,70 offiziell durch das BfArM zugelassener Test geeignet f�¼r Laienanwendungen schnelle Probenentnahme durch die Nase benutzerfreundliche Schritt-f�¼r-Schritt-Anleitung Testergebnis innerhalb von 15 Minuten LYHER Novel Coronavirus (COVID-19) Antigen Test Kit (Colloidal Gold) des Herstellers Hangzhou Laihe Biotech Co., Ltd., China
Corona Antigen Tests, single packed On Stock in 700 000 units immediately up to 1,2 million on the way and roll-over orders in line with producer without engagement, subject to prior sale
We are direct to the distributor of FlowFlex tests. We are based in the but can deliver to
I am representing SD Biosensor from South Korea that manufactures US FDA EUA approved Standard M nCo V Real-Time Detection Kit (COVID Testing kit). We have received US FDA EUA approval to export Covid 19 detection kit in April and can directly export from Korea. SD Biosensor is one of the few companies that has received US FDA approvals and have already sold 1.5 million testing units to US government (Based on US government reaching out to South Korea Government for help with procuring Covid Testing kits). I'm currently in Seoul, South Korea but I'm a US citizen helping SD Biosensor as an agent to help buyers procure these testing kits. This company has capability to manufacture over 600,000 testing units a day and have enough supplies readily available for an immediate export. Please email me at Jinsoo.park@yahoo.com to receive US FDA EUA Approval and product information. rapid test kits which are not FDA approved are in the low to mid $20 range and the price for FDA EUA approved standard test kits are around high $20s to low $30s and depending on the contract length and quantity we have some room for negotiation. Also these kits have to be refrigerated shipped so there will be some additional cost for this.
The test is a rapid colloidal gold immunochromatographic assay for the in vitro qualitative detection of the novel coronavirus(SARS-CoV-2), the influenza A virus (FluA) and the influenza B(FluB) antigen in human nasopharyngeal swab, oropharyngeal swab, nasal swab, and saliva samples from individuals suspected of respiratory viral infection.
Corona Antigen Rapid Test Kits USD 4.85 FOB.
Offering Safecare3 Covid 19 antigen + A+B flue, 1:3 combo tests, single packed, self testing, 2 years self time from my warehouse in Vilnius, Lithuania.
I am representing SD Biosensor from South Korea that manufactures US FDA EUA approved Standard M nCo V Real-Time Detection Kit (COVID Testing kit). We have received US FDA EUA approval to export Covid 19 detection kit in April and can directly export from Korea. SD Biosensor is one of the few companies that has received US FDA approvals and have already sold 1.5 million testing units to US government (Based on US government reaching out to South Korea Government for help with procuring Covid Testing kits). I'm currently in Seoul, South Korea but I'm a US citizen helping SD Biosensor as an agent to help buyers procure these testing kits. This company has capability to manufacture over 600,000 testing units a day and have enough supplies readily available for an immediate export. Please email me at Jinsoo.park@att.net to receive US FDA EUA Approval and product information. rapid test kits which are not FDA approved are in the low to mid $20 range and the price for FDA EUA approved standard test kits are around high $20s to low $30s and depending on the contract length and quantity we have some room for negotiation. Also these kits have to be refrigerated shipped so there will be some additional cost for this.
